Skip to main content
# Title Research Member Research Year
91 Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2019
92 Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome. Dr. Noha gaber sayed 2019
93 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Dr. Asmaa Mohamed Zahran Omar 2019
94 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom
Dr. Samar Muhammad mansour 2018
95 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute
Dr. Asmaa Mohamed Zahran Omar 2018
96 Telomere dysfunction-related serological markers and oxidative stress markers in rheumatoid arthritis patients: correlation with diseases activity Dr. Mohamed Galal Mostafa ELnaggar 2018
97 Frequency of ABCB1 Polymorphisms in Breast Cancer Patients in South Egypt Cancer Institute by High-Resolution Melting Curve Analysis
(Pilot Study)
Dina Ismeil Abd Elrazik 2018
98 circulating mi RNA-21 and miRNA-23 expression signature as potential biomarkers for early detection of non-small cell lung cancer Dr. Engy adel shafeek 2018
99 Serum Immunoglobulin Paraprotein in Patients with Chronic Lymphocytic Leukemia Dr. Asmaa Mohamed Zahran Omar 2018
100 HCMV Among Pediatrics Acute Lymphoblastic Leukemia Patients in South Egypt Cancer Institute Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2018